Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Asthma Health Center

Font Size

4 Asthma Drugs Get New Precaution

FDA Asks Singulair, Accolate, Zyflo, and Zyflo CR to Note Precaution About Reports of Behavior, Mood Changes
WebMD Health News
Reviewed by Louise Chang, MD

June 12, 2009 -- The FDA today asked makers of Singulair, Accolate, Zyflo, and Zyflo CR to include a precaution on those drugs' labels about reports of behavior and mood changes.

Singulair is used to treat asthma and symptoms of allergic rhinitis. Accolate, Zyflo, and Zyflo CR are used to treat asthma.

All four drugs are leukotriene inhibitors, which affect the leukotriene pathway, which is involved in the body's response to inflammatory stimuli (such as breathing in an allergen).

The FDA notes that some patients using those drugs have reported neuropsychiatric events (behavior or mood changes) including agitation, aggression, anxiousness, dream abnormalities and hallucinations, depression, insomnia, irritability, restlessness, suicidal thinking and behavior (including suicide), and tremor.

The FDA has already reviewed data from clinical trials about suicide risk in patients taking leukotriene inhibitors.

In that review, which the FDA released in January 2009, the FDA said it found no sign of a link between Singulair, Accolate, Zyflo, or Zyflo CR and suicide risk. At the time, the FDA said it was still reviewing clinical data on other behavioral and mood events.

FDA's Advice

On its web site, the FDA has posted the following advice about leukotriene inhibitors for patients and health care providers:

Patients and health care professionals should be aware of the potential for neuropsyschiatric events with these medications.

Patients should talk with their health care provider if these events occur.

Health care professionals should consider discontinuing these medications if patients develop neuropsychiatric symptoms.

Singulair is made by the drug company Merck. In a statement posted on its web site, Merck says that it has updated Singulair's prescribing information about adverse events reported after the drug went on the market, including the types of neuropsychiatric events mentioned today by the FDA.

"Merck will continue to work with the FDA to revise the prescribing information for Singulair in the United States to include a precaution related to those events," states Merck, adding that it is "confident in the safety and efficacy of Singulair, a medicine that has been prescribed to tens of millions of patients with asthma and allergic rhinitis since its approval more than 11 years ago."

Accolate is made by AstraZeneca. Zyflo and Zyflo CR are made by Cornerstone Pharmaceuticals. Those drug companies were not immediately available for comment on the FDA's label change request.

When Is Your Asthma Worse?

When Is Your Asthma Worse?

Take the WebMD Asthma assessment to get Personalized Action Plan

Start Now

Today on WebMD

Lung and bronchial tube graphic
5 common triggers.
group jogging in park
Should you avoid fitness activities?
asthma inhaler
Learn about your options.
man feeling faint
What’s the difference?
Madison Wisconsin Capitol
woman wearing cpap mask
red wine pouring into glass
Woman holding inhaler
Man outdoors coughing
Lung and bronchial tube graphic
10 Worst Asthma Cities